Safety Alerts & Recalls
What does this mean?
This recall for Wellbutrin XL 150 mg tablets was issued at a warehouse and pharmacy level only. The FDA and companies involved have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Wellbutrin XL 150 mg tablets and are concerned, you should follow up with your doctor.
Wellbutrin XL 150 mg: Single Lot Recalled
BTA Pharmaceuticals Inc. has recalled a single lot of Wellbutrin XL (Bupropion Hydrochloride Extended Release Tablets) 150 mg made by Biovail Corp. Lot number 10C094P has been recalled because some tablets in this lot failed the routine tests that measure the tablets' ability to dissolve and release the correct amount of medicine.
Wellbutrin XL contains the active ingredient bupropion and is commonly used in the treatment of depression. Bupropion is also made by other manufacturers. This recall alert only applies to the single lot of Wellbutrin XL 150 mg tablets. No other bupropion products were involved in this recall.
To view the FDA notice about this recall, please visit: more information here